Cita APA

Lebok, P., Huber, J., Burandt, E., Lebeau, A., Marx, A. H., Terracciano, L., . . . Quaas, A. (2016). Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer. Mol Med Rep.

Chicago Style Citation

Lebok, Patrick, et al. "Loss of Membranous VEGFR1 Expression Is Associated With an Adverse Phenotype and Shortened Survival in Breast Cancer." Mol Med Rep 2016.

Cita MLA

Lebok, Patrick, et al. "Loss of Membranous VEGFR1 Expression Is Associated With an Adverse Phenotype and Shortened Survival in Breast Cancer." Mol Med Rep 2016.